Due to immune evasion mechanisms by cancer as well as chronic inflammation in the cancer microenvironment, laryngeal SCC is frequently associated with upregulation of immune checkpoints such as PD-1, PD-L1, and CTLA-4 [43]. This evidence concerns the gene CTLA4 and cancer.